B. Flechl

发表

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors

C. Marosi, M. Preusser, A. Gaiger, 2012, Journal of Neuro-Oncology.

The caregivers’ perspective on the end-of-life phase of glioblastoma patients

M. Taphoorn, C. Marosi, J. Reijneveld, 2013, Journal of Neuro-Oncology.

Preservation of Neurocognition after Proton Beam Radiation Therapy for Intracranial Tumors: First Results from REGI-MA-002015.

P. Georg, E. Hug, C. Lütgendorf-Caucig, 2022, International journal of radiation oncology, biology, physics.

The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy

P. Georg, M. Stock, C. Marosi, 2022, Strahlentherapie und Onkologie.

The Value of SSTR2 Receptor-Targeted PET/CT in Proton Irradiation of Grade I Meningioma

R. Galalae, E. Hug, M. Mumot, 2021, Cancers.

Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients

C. Marosi, C. Krall, G. Widhalm, 2012, Wiener klinische Wochenschrift.

End of life care in high-grade glioma patients in three European countries: a comparative study

M. Taphoorn, C. Marosi, J. Reijneveld, 2014, Journal of Neuro-Oncology.

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes

P. Georg, R. Galalae, E. Hug, 2022, Frontiers in Oncology.

Case Report: Pregnancy in a patient with recurrent glioblastoma

C. Marosi, C. Kurz, P. Balcke, 2013, F1000Research.

Assessment of improved organ at risk sparing for meningioma: light ion beam therapy as boost versus sole treatment option.

D. Georg, S. Vatnitsky, K. Dieckmann, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Austrian Patients with Glioblastoma Multiforme and Their Families: Socioeconomic Aspects

C. Marosi, B. Flechl, 2013 .

Response to imatinib as a function of target kinase expression in recurrent glioblastoma

C. Marosi, J. Hainfellner, M. Preusser, 2014, SpringerPlus.

Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO).

J. Pichler, C. Marosi, J. Hainfellner, 2013, Neuro-oncology.

Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma.

C. Marosi, J. Hainfellner, M. Preusser, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma.

C. Marosi, J. Hainfellner, M. Preusser, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Sorafenib for patients with pretreated recurrent or progressive high-grade glioma: a retrospective, single-institution study

C. Marosi, J. Hainfellner, M. Preusser, 2014, Anti-cancer drugs.

Thalidomide as Palliative Treatment in Patients with Advanced Secondary Glioblastoma

C. Marosi, D. Prayer, J. Hainfellner, 2014, Oncology.

Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience

P. Georg, M. Stock, E. Hug, 2023, Cancers.

Case Report: Pregnancy in a patient with recurrent glioblastoma [version 1; peer review: 2 approved]

M. Hassler, B. Flechl, G. Kopetzky, 2022 .

Article Status Summary Referee Responses Case Report: Pregnancy in a Patient with Recurrent Glioblastoma

C. Marosi, C. Kurz, P. Balcke, 2022 .

The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma.

C. Marosi, J. Hainfellner, A. Woehrer, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Meningioma WHO I with involvement of the optical structures—does proton therapy lead to changes in quality of life with regard to subjective visual performance?

P. Georg, E. Hug, P. Fossati, 2022, Strahlentherapie und Onkologie.